Research programme: Sn 117m-labelled mannose receptor-targeted diagnostics and therapeutics - R-NAV
Alternative Names: Sn 117m tilmanocept - R-NAV; Tin-117m tilmanocept - R-NAV; Tin-117m-labelled mannose receptor-targeted diagnostics and therapeutics - R-NAVLatest Information Update: 28 Aug 2018
Price :
$50 *
At a glance
- Originator R-NAV
- Class Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
- Mechanism of Action Macrophage modulators; Mannose receptor modulators; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Joint disorders; Osteoarthritis; Rheumatoid arthritis
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for research development in Joint-disorders(In adolescents, In children, In infants) in USA
- 28 Aug 2018 No recent reports of development identified for research development in Osteoarthritis in USA
- 28 Aug 2018 No recent reports of development identified for research development in Osteoarthritis(Diagnosis) in USA